Announcements Trials
Browse Landscape

Phase

Phase 1 12Phase 1/2 5Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 12Recruiting 10Unknown 5Not yet recruiting 5Active not recruiting 2Terminated 1Suspended 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Carcinoma, Non-Small-Cell Lung 72Breast Neoplasms 63Neoplasms 59Leukemia, Myeloid, Acute 59Multiple Myeloma 53Colorectal Neoplasms 48Lymphoma 46Recurrence 45Carcinoma, Hepatocellular 45Stomach Neoplasms 43Pancreatic Neoplasms 40Neoplasm Metastasis 39Prostatic Neoplasms 34Melanoma 34Leukemia 30Lymphoma, Non-Hodgkin 27Lymphoma, B-Cell 27Lung Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Glioblastoma 24Ovarian Neoplasms 23Lymphoma, Large B-Cell, Diffuse 21Esophageal Neoplasms 21Carcinoma, Renal Cell 20Myelodysplastic Syndromes 19Leukemia, Lymphocytic, Chronic, B-Cell 19Hematologic Neoplasms 19Colonic Neoplasms 19Head and Neck Neoplasms 18Lymphoma, Mantle-Cell 17

Interventions

lenvatinib 1Infusions, Intravenous 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Solid Tumors × Clear all
NCT05740215 2023-02-22

Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors

Shandong New Time Pharmaceutical Co., LTD

Phase 1/2 Unknown
158 enrolled
Other solid neoplasm

Solid Tumors

NCT05524194 2022-09-01

6MW3511 in Patients With Advanced Solid Tumor

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1/2 Unknown
272 enrolled
Other solid neoplasm

Solid Tumors

NCT05216965 2022-06-15

A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1/2 Unknown
208 enrolled
Other solid neoplasm

Solid Tumors

NCT04937842 2021-06-24

Microtransplantation for Advanced and Relapsed Solid Tumors

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Phase 1/2 Unknown
60 enrolled
Other solid neoplasm

Solid Tumors

NCT02858232 2016-08-11

MASCT-I Treatment for Advanced Solid Tumor

The First People's Hospital of Lianyungang

Phase 1/2 Unknown
46 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡